Ekso Bionics Announces Research Partnership with Shepherd Center
June 25, 2024 08:00 ET
|
Ekso Bionics Holdings, Inc.
Collaboration Expands Use of EksoNR and Ekso Indego Devices in Rehabilitation and Community Settings to Better Improve Patient Quality of Life SAN RAFAEL, Calif., June 25, 2024 (GLOBE NEWSWIRE) --...
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors
June 17, 2024 16:05 ET
|
Ekso Bionics Holdings, Inc.
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE...
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky
May 10, 2024 08:00 ET
|
Ekso Bionics Holdings, Inc.
Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ETSAN RAFAEL, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...
Ekso Bionics Announces First Quarter 2024 Financial Results
April 29, 2024 16:05 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and...
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
April 22, 2024 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
April 12, 2024 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and...
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
March 04, 2024 16:05 ET
|
Ekso Bionics Holdings, Inc.
Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in...
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
February 26, 2024 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces $4.6 Million Registered Direct Offering
January 11, 2024 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Launches GaitCoach Software for EksoNR
January 08, 2024 16:05 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...